Medtronic
MDT · NYSE
Bulios Fair Price
$47.12
48.2% downside
Current Price
$90.98
According to Bulios Fair Price, MDT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Medtronic plc is an international company operating in the field of medical technology. The company is one of the leaders in the development, manufacturing, and distribution of medical devices and therapeutic solutions for various healthcare needs. Medtronic focuses on innovative products and solutions that assist patients with various medical conditions, such as heart diseases, diabetes, neurological disorders, orthopedic issues, and more. The company is known for its implantable medical devices, including pacemakers, insulin pumps, neurostimulation devices, and orthopedic implants. Medtronic strives to improve the lives of patients and provide innovative medical technologies that bring healing and life-enhancing benefits. The company collaborates with physicians, hospitals, and healthcare institutions to develop and deliver the latest medical solutions. Medtronic plc (MDT) shares are an interesting choice for investors who follow the healthcare sector and seek investment opportunities in a respected company that is an innovator in the field of medical technologies.
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha
Employees
95,000
Headquarters
Galway
Upcoming events
Ex-Dividend
Ex-dividend date
Dividend Payment
Payment date
Earnings
Upcoming earnings report